Neuronetics, Inc. — Director's Dealing 2023

Dec 22, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuronetics, Inc. (STIM)
CIK: 0001227636
Period of Report: 2023-12-19

Reporting Person: MACAN WILLIAM ANDREW (EVP, GC, CCO and CS)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-19	Common Stock	S	11664	$2.24	Disposed	372069	Direct
2023-12-20	Common Stock	S	11664	$2.70	Disposed	360405	Direct
2023-12-21	Common Stock	S	11663	$2.52	Disposed	348742	Direct

Footnotes

F1: The sales reported in this Form 4 were pursuant to a 10b5-1 plan validly adopted by the reporting person on on August 28, 2023.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.13 to $2.50. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.42 to $2.90. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.46 to $2.61. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.